Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test
Test Name: Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test
Components: Price: 1340.0 AED
Sample Condition: PCR: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended. FLOW: 4 mL (3 mL min.) whole blood from 1 Lavender Top (EDTA) tube AND 1 Green top (Sodium Heparin) tube each. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on Test Request form.
Report Delivery: Sample – Wed / Sat by 11 am; Report – Fri / Tue
Method: Real Time RT-PCR, Flow Cytometry
Test Type: AIDS
Doctor: Physician
Test Department:
Pre Test Information: 12 hours fasting is recommended.
Test Details
The Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test is a diagnostic test used to measure the amount of HIV-1 RNA in the blood. It also includes the analysis of CD3, CD4, and CD8 markers, which are important for assessing the immune system’s response to HIV infection.
The test is performed using a technique called real-time polymerase chain reaction (PCR), which allows for the detection and quantification of HIV-1 RNA. The CD3, CD4, and CD8 markers are analyzed to determine the levels of T lymphocytes in the blood. T lymphocytes play a crucial role in the immune response to HIV infection, and their levels can provide valuable information about the progression of the disease.
This test is typically used for monitoring the effectiveness of antiretroviral therapy (ART) in HIV-infected individuals. By measuring the amount of HIV-1 RNA in the blood and assessing the levels of CD3, CD4, and CD8 markers, healthcare providers can evaluate the response to treatment and make adjustments if necessary.
It is important to note that this test is specifically designed for HIV-1 and does not detect other strains or subtypes of HIV. Additionally, it is not a screening test for HIV infection, but rather a tool for monitoring disease progression and treatment response in individuals already diagnosed with HIV.
Overall, the Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test provides valuable information about the viral load and immune status of HIV-infected individuals, aiding in the management of the disease.
Test Name | Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test |
---|---|
Components | |
Price | 1340.0 AED |
Sample Condition | PCR: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended.\n FLOW: 4 mL (3 mL min.) whole blood from 1 Lavender Top (EDTA) tube AND 1 Green top (Sodium Heparin) tube each. Ship at 18-22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on Test Request form. |
Report Delivery | SampleWed / Sat by 11 am; ReportFri / Tue |
Method | Real Time RT-PCR, Flow Cytometry |
Test type | AIDS |
Doctor | Physician |
Test Department: | |
Pre Test Information | 12 hours fasting is recommended. |
Test Details |
The Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test is a diagnostic test used to measure the amount of HIV-1 RNA in the blood. It also includes the analysis of CD3, CD4, and CD8 markers, which are important for assessing the immune system’s response to HIV infection. The test is performed using a technique called real-time polymerase chain reaction (PCR), which allows for the detection and quantification of HIV-1 RNA. The CD3, CD4, and CD8 markers are analyzed to determine the levels of T lymphocytes in the blood. T lymphocytes play a crucial role in the immune response to HIV infection, and their levels can provide valuable information about the progression of the disease. This test is typically used for monitoring the effectiveness of antiretroviral therapy (ART) in HIV-infected individuals. By measuring the amount of HIV-1 RNA in the blood and assessing the levels of CD3, CD4, and CD8 markers, healthcare providers can evaluate the response to treatment and make adjustments if necessary. It is important to note that this test is specifically designed for HIV-1 and does not detect other strains or subtypes of HIV. Additionally, it is not a screening test for HIV infection, but rather a tool for monitoring disease progression and treatment response in individuals already diagnosed with HIV. Overall, the Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test provides valuable information about the viral load and immune status of HIV-infected individuals, aiding in the management of the disease. |